<pre>
 
<p>
-------------------------------------------------------------------------------
help for <b>midas9</b>                                           (Ben Adarkwa Dwamena)
<p>
-------------------------------------------------------------------------------
<p>
<b><u>midas9 -- Meta-analytical Integration of Diagnostic Accuracy Studies</u></b>
<p>
<b><u>Syntax</u></b>
<p>
        <b>midas9</b> <i>varlist</i> [<b>if</b> <i>exp</i>] [<b>in</b> <i>range</i>] [<b>,</b> <b>id(</b><i>varname</i><b>)</b> <b>year(</b><i>varname</i><b>)</b>
                  <i>modeling_options</i> <i>quality_assessment_options</i>
                  <i>reporting_options</i> <i>exploratory_graphics_options</i>
                  <i>publication_bias_Options</i> <i>forest_plot_options</i>
                  <i>heterogeneity_options</i> <i>roc_options</i>
                  <i>probability_revision_options</i> <i>general_graphing_options</i> *]
<p>
            <i>modeling_options</i> may be <b>nip(</b><i>integer 15</i><b>)</b> <b><u>es</u></b><b>timator()</b>
<p>
            <i>quality_assessment_options</i> may be <b><u>qualit</u></b><b>ab</b> <b><u>qualib</u></b><b>ar</b> <b>qlab</b>
<p>
            <i>reporting_options</i> may be <b><u>res</u></b><b>ults()</b> <b><u>tab</u></b><b>le()</b>
<p>
            <i>exploratory_graphics_options</i> may be <b><u>chip</u></b><b>lot</b> <b><u>biv</u></b><b>box</b> <b><u>qq</u></b><b>plot</b> <b>cum</b> <b>inf</b>
<p>
            <i>publication_bias_options</i> may be <b><u>pubb</u></b><b>ias</b> <b><u>fun</u></b><b>nel</b> <b>maxbias</b>
<p>
            <i>forest_plot_options</i> may be <b><u>for</u></b><b>est()</b> <b><u>ford</u></b><b>ata</b>
<p>
            <i>heterogeneity_options</i> may be <b>galb()</b> <b><u>het</u></b><b>for</b> <b><u>cov</u></b><b>ars</b>
<p>
            <i>roc_curve_options</i> may be <b>sroc1</b> <b>sroc2</b> <b><u>rocp</u></b><b>lane</b>
<p>
            <i>probability_revision_options</i> may be <b>pddam()</b> <b>fagan</b> <b>prior()</b>
            <b><u>lrm</u></b><b>atrix</b>
<p>
            and <i>general_graphing_options</i> may be <b><u>plot</u></b><b>type(</b><i>string</i><b>)</b>
            <b><u>test</u></b><b>lab(</b><i>string</i><b>)</b> <b>csize(</b><i>real 36</i><b>)</b> <b>hsize(</b><i>integer 6</i><b>)</b> <b>vsize(</b><i>integer 8</i><b>)</b>
            <b>level(</b><i>integer 95</i><b>)</b> <b><u>ms</u></b><b>cale(</b><i>real 0</i>.<i>50</i><b>)</b> <b><u>texts</u></b><b>cale(</b><i>real 0</i>.<i>85</i><b>)</b> <b>zcf(</b><i>real</i>
            <i>0</i>.<i>5</i><b>)</b>
<p>
 
    <b>by</b><i>...</i><b>:</b> may be used with midas9; see help by.
<p>
<p>
<b><u>Description</u></b>
<p>
        midas9 is a comprehensive program of statistical and graphical
        routines for undertaking meta-analysis of diagnostic test performance
        in Stata.
<p>
        Primary data synthesis is performed within the bivariate mixed-efects
        binary regression modeling framework. Model specification, estimation
        and prediction are carried out with gllamm(Rabe-Hesketh et.al) in
        release 9, by adaptive quadrature.
<p>
        Using the model estimated coefficients and variance-covariance
        matrices, midas9 calculates summary operating sensitivity and
        specificity (with confidence and prediction contours in SROC space),
        summary likelihood and odds ratios. Global and relevant test
        performance metric-specific heterogeneity statistics are provided.  
        midas9 facilitates extensive statistical and graphical data synthesis
        and exploratory analyses of heterogeneity, covariate effects,
        publication bias and influence.
<p>
        Bayes' nomograms and likelihood ratio matrices may be obtained and
        used to guide clinical decision-making.
<p>
        The minimum required varlist is the data from contingency tables of
        test results.  The user provides the data in a rectangular array
        containing variables for the 2x2 elements a, b, c, and d:
<p>
           2x2    +---------------------+
          table   |        Test         |
        +---------+----------+----------+    where:
        | Truth   | Positive | Negative |       a = true positives,
        +---------+----------+----------+       b = false positives,
        | Case    |    a     |    c     |       c = false negatives,
        +---------+----------+----------+       d = true negatives.
        | Noncase |    b     |    d     |
        +---------+----------+----------+
<p>
<p>
        Each data file row contains the 2x2 data for one observation (i.e.,
        study).
<p>
        <b>id(</b><i>varname</i><b>)</b> <b>year(</b><i>varname</i><b>)</b>, if provided , is concatenated to create a
        study identification variable. Default uses observation number for
        id.
<p>
        The varlist MUST contain variables for a, b, c, and d in that order.
<p>
<p>
<p>
        Note: midas9 requires release 10 to implement modeling with xtmelogit
        or Stata version 9 for estimation with gllamm (mainly because of use
        of paired coordinate arrow graphics not available before release 9);
<p>
<p>
        User should install (if not installed) metan and mylabels for either
        estimator and also gllamm if using release 9.
<p>
        +----------+
    ----+ Modeling +---------------------------------------------------------
 
        <b>nip</b> specifies the number of integration points used for maximum
        likelihood estimation based on adaptive gaussian quadrature.  Default
        is set at 15 for <b>midas9</b> even though the default in xtmelogit is 7.
        Higher values improve accuracy at the expense of execution times.
        The only values currently supported by gllamm are 5, 7, 9, 11 and 15
        (Rabe-Hesketh &amp; Skrondal 2005}, appendix B.)
<p>
        Using xtmelogit with <b>nip(</b><i>1</i><b>)</b>, model will be estimated by Laplacian
        approximation. This decreases substantially computational time and
        yet provides reasonably valid fixed effects estimates.  It may,
        however, produce biased estimates of the variance components.
<p>
        <b><u>es</u></b><b>timator(</b><i>g</i>|<i>x</i><b>)</b> provides a choice between estimation with xtmelogit in
        release 10 versus gllamm in version 9 or earlier.
<p>
        The following options MUST have an estimator inorder to work!
        <b>pddam()</b>, <b>fagan</b>, <b><u>for</u></b><b>est()</b>,<b><u>rocp</u></b><b>lane</b>, <b>sroc1</b>, <b>sroc2</b>, <b><u>het</u></b><b>for</b>, <b><u>res</u></b><b>ults()</b>,
        <b><u>tab</u></b><b>le()</b> and <b><u>lrm</u></b><b>atrix</b>.  if estimator is missing, midas9 will issue an
        error message.
<p>
        +--------------------+
    ----+ Quality_Assessment +-----------------------------------------------
<p>
        <b><u>qualit</u></b><b>ab</b> creates, using optional varlist of study quality items
        (presence=1, other=0) a table showing frequency of methodologic
        quality items.
<p>
        <b><u>qualib</u></b><b>ar</b> creates, combined with optional varlist of study quality
        items (presence=1, other=0) calculates study-specific quality scores
        and plots a bargraph of methodologic quality.
<p>
        <b>qlab</b> may be combined with <b>qualitab</b> or <b>qualibar</b> to use variable labels
        for table and bargraph of methodologic items.
<p>
        +-----------+
    ----+ Reporting +--------------------------------------------------------
<p>
        <b><u>res</u></b><b>ults(</b><i>all</i><b>)</b> provides summary statistics for all performance indices,
        group-specific between-study variances, likelihood rato test
        statistics and other global homogeneity tests.
<p>
        <b><u>res</u></b><b>ults(</b><i>het</i><b>)</b> provides group-specific between-study variances,
        likelihood rato test statistics and other global homogeneity tests.
<p>
        <b><u>res</u></b><b>ults(</b><i>sum</i><b>)</b> provides summary statistics for all performance indices
<p>
        <b><u>tab</u></b><b>le(</b><i>dss</i>|<i>dlr</i>|<i>dlor</i><b>)</b> will create a table of study specific performance
        estimates with measure-specific summary estimates and results of
        homogeneity (chi_squared) and inconsistency(I_squared) tests.  <b>dss</b>,
        <b>dlr</b> or <b>dlor</b> represent the paired performance measures
        sensitivity/specificity, positive/negative likelihood ratios and
        diagnostic score/odds ratios.
<p>
        +----------------------+
    ----+ Exploratory Graphics +---------------------------------------------
<p>
        <b>bivbox</b> implements a two-dimensional analogue of the boxplot for
        univariate data similar to the bivariate boxplot (Goldberg and
        Iglewicz,1992). It is used to assess distributional properties of
        sensitivity versus specificity and for indentifying possible
        outliers.
<p>
        <b><u>chi</u></b><b>plot</b> creates a chiplot (Fisher &amp; Switzer, 1985, 2001) for judging
        whether or nor the paired performance indices are independent by
        augmenting the scatterplot with an auxiliary display. In the case of
        independence, the points will be concentrated in the central region,
        in the horizontal band indicated on the plot.
<p>
        <b><u>qq</u></b><b>plot(</b><i>dss</i>|<i>dlor</i>|<i>dlr</i><b>)</b> plots a normal quantile plot to (a) check the
        normality assumption (b) investigate whether all studies come from a
        single population (c) search for publication bias (Wang and Bushman,
        1998).
<p>
        <b>cum</b> produces a cumulative meta-analysis plot showing how evidence has
        accumulated over time using metan (most current version must be
        installed and may be obtained my typing {ssc install metan,
        replace}).  midas9 uses year of publication as measure for temporal
        evolution of evidence.
<p>
        Results are displayed graphically using <b>serrbar</b>.  The ith line on the
        plot is the summary produced by a meta-analysis of the first ith
        trials.
<p>
        <b>inf</b> investigates the influence of each individual study on the
        overall meta-analysis summary estimate. This option presents a 
        serrbar of the results of an influence analysis in which the
        meta-analysis is reestimated omitting each study in turn, using metan
        (most current version must be installed).
<p>
 
        +------------------+
    ----+ Publication Bias +-------------------------------------------------
<p>
        <b><u>pubb</u></b><b>ias</b> When this option is invoked, midas9 performs linear
        regression of log odds ratios on inverse root of effective sample
        sizes as a test for funnel plot asymmetry in diagnostic metanalyses.
        A non-zero slope coefficient is suggestive of significant small study
        bias(pvalue &lt; 0.10).
<p>
        <b><u>max</u></b><b>bias</b> performs Copas' worst-case sensitivity analysis for
        publication bias. It calculates the upper bound number of missing
        studies that will overturn statistical significance and estimates the
        minimun likely publication probability (Copas and Jackson, 2004).
<p>
        <b><u>fun</u></b><b>nel</b> plots a funnel plot, a two-dimensional graph with sample size
        on one axis and effect-size estimate on the other axis. The funnel
        plot capitalizes on the well-known statistical principle that
        sampling error decreases as sample size increases.
<p>
        In a meta-analysis, the funnel plot can be used to investigate
        whether all studies come from a single population and to search for
        publication bias.
<p>
<p>
        +--------------+
    ----+ Forest Plots +-----------------------------------------------------
<p>
        <b><u>for</u></b><b>est(</b><i>dss</i>|<i>dlr</i>|<i>dlor</i><b>)</b> creates summary graphs with study-specific(box)
        and overall(diamond) point estimates and confidence intervals for
        each performance index pair using graph combine. Confidence intervals
        lines are allowed to extend between 0 and 1000 beyond which they are
        truncated and marked by a leading arrow.
<p>
        <b><u>ford</u></b><b>ata</b> adds study-specific performance estimates and 95% CIs to
        right y-axis.
<p>
        +---------------+
    ----+ Heterogeneity +----------------------------------------------------
<p>
        <b>galb(</b><i>dss</i>|<i>dlr</i>|<i>dlor</i><b>)</b> The standardized effect measure (e.g. for lnDOR,
        lnDOR/precision) is plotted (y-axis) against the inverse of the
        precision(x-axis). A regression line that goes through the origin is
        calculated, together with 95% boundaries (starting at +2 and -2 on
        the y-axis).  Studies outside these 95% boundaries may be considered
        as outliers.
<p>
        <b><u>het</u></b><b>for</b> creates composite forest plot of all performance indices to
        provide a general view of variability.Confidence intervals lines are
        allowed to extend between 0 and 1000 beyond which they are truncated
        and marked by a leading arrow.
<p>
        <b><u>cov</u></b><b>ars</b> combined with an optional varlist permits univariable
        metaregression analysis of one or multiple covariables.
<p>
        +------------+
    ----+ ROC Curves +-------------------------------------------------------
<p>
        <b>sroc1</b> plots observed datapoints, summary operating sensitivity and
        specificity in SROC space.
<p>
        <b>sroc2</b> adds confidence and prediction contours.
<p>
        <b><u>roc</u></b><b>plane</b> plots observed data in receiver operating characteristic
        space (ROC Plane) for visual assessment of threshold effect.
<p>
        +-------------------------------+
    ----+  Probability Revision Options +------------------------------------
<p>
        <b>fagan</b> creates a plot showing the relationship between the prior
        probability, the likelihood ratio(combination of sensitivity and
        specificity), and posterior test probability.
<p>
        <b>prior()</b> combined with <b>fagan</b> allows user to specify a pretest
        probability overriding the default of using disease prevalence
        calculated from data when <b>fagan</b> is invoked alone.
<p>
        <b>pddam(</b><i>p</i>|<i>r</i><b>)</b> produces a line graph of post-test probalities versus
        prior probabilities between 0 and 1 using summary likelihood ratios
<p>
        <b><u>lrm</u></b><b>atrix</b> creates a scatter plot of positive and negative likelihood
        ratios with combined summary point. Plot is divided into quadrants
        based on strength-of-evidence thresholds to determine informativeness
        of measured test.
<p>
<p>
        +------------------+
    ----+ Graphing Options +-------------------------------------------------
<p>
        <b><u>plot</u></b><b>type(</b><i>string</i><b>)</b> will add type of plot to title of plot
<p>
        <b><u>test</u></b><b>lab(</b><i>string</i><b>)</b> will add any descriptive string to title of plot
<p>
        <b>csize()</b> allows user to modify relative sizes of combined forest plots
        along the x axis.
<p>
        <b>hsize()</b> allows user to modify size of other plots along the x axis.
<p>
        <b>vsize()</b> allows user to modify relative sizes of combined forest plots
        along the y axis.
<p>
        <b>level()</b> specifies the significance level for statistical tests,
        confidence contours, prediction contours and confidnce intervals.
<p>
        <b>mscale()</b> affects size of markers for point estimates on forest plots.
<p>
        <b>scheme(</b><i>string</i><b>)</b> permits choice of scheme for graphs. The default is
        s2color.
<p>
        <b><u>texts</u></b><b>cale()</b> allows choice of text size for graphs especially
        regarding labels for forest plots.
<p>
        <b>zcf()</b> defines a fixed continuity correction to add in the case where
        a study contains a zero cell. By default, midas9 adds 0.5 to each
        cell of a study where a zero is encountered for logit and log
        transformations, only to calculate study-specific likelihood ratios
        and odds ratios. However, the <b>zcf()</b> option allows the use of other
        constants between 0 and 1.
<p>
<b><u> Remarks on test performance metrics:</u></b>
<p>
        Sensitivity and specificity , diagnostic odds ratio and likelihood
        ratios with 95% confidence intervals, are recalculated for each
        primary study from the contingency tables of true-positive [a],
        false-positive [b], false-negative results [c], and true-negative
        [d].
<p>
        A four-fold (two by two contingency) table comparing test results for
        a diagnostic/screening test is identical to a four-fold table
        comparing outcomes of an experimental application of an intervention
        (Skupski, Rosenberg and Eglinton, 2002).
<p>
        For an interventional trial, the true positives are the experimental
        group with the monitored outcome present [a].The false positives are
        the control group with the outcome present [b]. The false negatives
        are the experimental group with the outcome absent [c]. The true
        negatives are the control group with the outcome absent [d]. The
        expression for the relative risk in the experimental group {[a/ (a +
        c)]/ [b/ (b + d)]} is identical to the expression for the likelihood
        ratio for a positive test in an evaluation of a diagnostic or a
        screening methodology.  Similarly, the expression for the relative
        risk in the control group in an interventional trial is identical to
        the expression for the likelihood ratio for a negative test(Skupski,
        Rosenberg and Eglinton, 2002).  The LRs indicate by how much a given
        test would raise or lower the probability of having disease. In order
        for diagnostic informativeness to be high, an LR of &gt; 10 or &lt; 0.1
        would be required for a positive and negative test result,
        respectively. Moderate informational value can be achieved with LR
        values of 5-10 and 0.1-0.2; LRs of 2-5 and 0.2-0.5 have very small
        informational value.
<p>
        The diagnostic odds ratio of a test is the ratio of the odds of
        positivity in disease relative to the odds of positivity in the
        nondiseased (Glas, Lijmer, Prins, Bonsel and Bossuyt, 2003). The
        expression for the odds ratio (DOR) is (a × d)/(b × c). The value of
        a DOR ranges from 0 to infinity, with higher values indicating better
        discriminatory test performance.  A value of 1 means that a test does
        not discriminate between patients with the disorder and those without
        it. Values lower than 1 point to improper test interpretation (more
        negative tests among the diseased).  The diagnostic odds ratio (DOR)
        may be used as a single summary measure with the caveat that the same
        odds ratio may be obtained with different combinations of sensitivity
        and specificity (Glas, Lijmer, Prins, Bonsel and Bossuyt, 2003)
<p>
        The area under the curve (AUROC), obtained by trapezoidal
        integration, serves as a global measure of test performance.  The
        AUROC is the average TPR over the entire range of FPR values.  The
        following guidelines have been suggested for interpretation of
        intermediate AUROC values:  low (0.5&gt;= AUC &lt;= 0.7), moderate (0.7 &gt;=
        AUC &lt;= 0.9), or high (0.9 &gt;= AUC &lt;= 1) accuracy (Swets, 1988).
<p>
<p>
<p>
<b><u>Remarks on Meta-analytic Model:</u></b> 
<p>
        Primarily, midas9 uses an exact binomial rendition (Chu &amp; Cole, 2006)
        of the bivariate mixed-effects regression model developed by von
        Houwelingen(von Houwelingen, 1993, 2001) for treatment trial
        meta-analysis and modified for synthesis of diagnostic test data
        (Reitsma, 2005; Riley, 2006).
<p>
        It fits a two-level model, with independent binomial distributions
        for the true positives and true negatives conditional on the
        sensitivity and specificity in each study and a bivariate normal
        model for the logit transforms of sensitivity and specificity between
        studies.
<p>
        The standard output of the bivariate model includes: mean logit
        sensitivity and specificity with their standard errors and 95%
        confidence intervals; and estimates of the between-study variability
        in logit sensitivity and specificity and the covariance between them.
<p>
        Based on these parameters, we can calculate other measures of
        interest such as the likelihood ratio for positive and negative test
        results, the diagnostic odds ratio, the correlation between logit
        sensitivity and specificity, several summary ROC linear regression
        lines based on either the regression of logit sensitivity on
        specificity, the regression of logit specificity on sensitivity, or
        an orthogonal regression line by minimizing the perpendicular
        distances.  These lines can be transformed back to the originalROC
        scale to obtain a summary ROC curve. Summary sensitivity,
        specificity, and the corresponding positive likelihood, negative
        likelihood and diagnostic odds ratios are drived as functions of the
        estimated model parameters; The derived logit estimates of
        sensitivity, specificity and respective variances are used to
        construct a hierarchical summary ROC curve.
<p>
<p>
<b><u>Remarks on assessment and exploration of heterogeneity:</u></b> 
<p>
        Heterogeneity means that there is between study variation.
        Galbraith(radial) plot is used to visually identify outliers.  To
        construct this plot, the standardized lnDOR = lnDOR/se is plotted
        (y-axis) against the inverse of the se (1/se) (x-axis).  A regression
        line that goes through the origin is calculated, together with 95%
        boundaries (starting at +2 and -2 on the y-axis).  Studies outside
        these 95% boundaries may be considered as outliers.
<p>
        Many sources of heterogeneity can occur: characteristics of the study
        population, variations in the study design (type of design, selection
        prodedures, sources of information, how the information is
        collected), different statistical methods, and different covariates
        adjusted for (if relevant) (Dinnes, 2005). Heterogeneity (or absence
        of homogeneity) of the results between the studies is assessed
        graphically by forest plots and statistically using the quantity I2
        that describes the percentage of total variation across studies that
        is attributable to heterogeneity rather than chance (Higgins, 2003).
<p>
        I2 can be calculated from basic results as I2 = 100% x (Q - df)/Q,
        where Q is Cochran's heterogeneity statistic and df the degrees of
        freedom. (Higgins, 2003). Negative values of I2 are made equal to 0
        so that I2 lies between 0% and 100%.  A value of 0% indicates no
        observed heterogeneity, and values greater than 50% may be considered
        substantial heterogeneity.  The main advantage of I2 is that it does
        not inherently depend on the number of the studies in the
        meta-analysis.
<p>
        Formal investigation of heterogeneity is performed by multiple
        univariable bivariate meta-regression models.  Covariates are
        manipulated as mean-centered continuous or as dichotomous (yes=1, no=
        0) fixed effects.  The effect of each covariate on sensitivity is
        estimated separately from that on specificity.  Metaregression is a
        collection of statistical procedures (weighted/unweighted linear,
        logistic regression) to assess heterogeneity, in which the effect
        size of study is regressed on one or several covariates, with a value
        defined for each study.
<p>
<p>
<b><u>Remarks on Publication bias:</u></b>
<p>
        Publication bias is produced when the published studies do not
        represent adequately all the studies carried out on a specific topic
        (Begg and Berlin). This bias may be caused by factors such as the
        trend to publish statistically significant (p &lt; 0.05) or clinically
        relevant (high magnitude albeit non-significant) results.  Other
        variables influencing publication bias (Song, 2002) are sample size
        (more in small studies), type of design, funding, conflict of
        interest, prejudice against an observed association, sponsorship.
<p>
        Publication bias is assessed visually by using a scatter plot (Light
        and Pillemer, 1984) of the inverse of the square root of the
        effective sample size (1/ESS1/2) versus the diagnostic log odds
        ratio(lnDOR) which should have a symmetrical funnel shape when
        publication bias is absent (Deeks, 2005).
<p>
        Separate funnel plots for sensitivity and specificity (after logit
        transformation) are unlikely to be helpful for detecting sample size
        effects, because sensitivities and specificities will vary due to
        both variability of threshold between the studies and random
        variability. Simultaneous interpretation of two related funnel plots
        and two tests for funnel plot asymmetry also presents challenges.
        Formal testing for publication bias may be conducted by a regression
        of lnDOR against 1/ESS1/2, weighting by ESS (Deeks, 2005), with P &lt;
        .05 for the slope coefficient indicating significant asymmetry.
<p>
        An alternative graphical test of publication bias may be derived by
        assessing the linearity of the Normal quantile plot (Wang and
        Bushman, 1998). This plot compares the quantiles of an observed
        distribution against the quantiles of the standard Normal
        distribution. In a meta-analysis, such a plot can be used to check
        the Normality assumption, investigate whether all studies come from a
        single population, and search for publication bias (Wang and Bushman,
        1998).
<p>
<b><u> Remarks on Cumulative meta-analysis:</u></b>
<p>
        Cumulative meta-analysis is a type of meta-analysis in which studies
        are sequentially pooled by adding each time one new study according
        to an ordered variable. For instance, if the ordered variable is the
        year of publication, studies will be ordered by it; then, a pooling
        analysis will be done every time a new article appears.  It shows the
        evolution of the pooled estimate according to the ordered variable.
        Other common variables used in cumulative meta-analysis are the study
        quality, the risk of the outcome in the control group, the size of
        the difference between the groups, and other covariates.
<p>
<b><u> Remarks on Clinical Application:</u></b>
<p>
        The clinical or patient-relevant utility of diagnostic test is
        evaluated using the likelihood ratios to calculate post-test
        probability based on Bayes' theorem as follows (Jaeschke, 1994):
        Pretest Probability=Prevalence of target condition
<p>
        Post-test probability= likelihood ratio x pretest
        probability/[(1-pretest probability) x (1-likelihood ratio)]
<p>
        Assuming that the study samples are representative of the entire
        population, an estimate of the pretest probability of target
        condition is calculated from the global prevalence of this disorder
        across the studies.
<p>
        In this way, likelihood ratios are more clinically meaningful than
        sensitivities or specificities.  This approach would be useful for
        the clinicians who might use the likelihood ratios generated from
        here to calculate the post-test probabilities of nodal disease based
        on the prevalence rates of their own practice population.
<p>
        Thus, this approach permits individualization of diagnostic evidence.
        This concept is depicted visually with Fagan's nomograms. When Bayes
        theorem is expressed in terms of log-odds, the posterior log-odds are
        linear functions of the prior log-odds and the log likelihood ratios.
        <b>fagan</b> plots an axis on the left with the prior log-odds, an axis in
        the middle representing the log likelihood ratio and an axis on the
        right representing the posterior log-odds. Lines are then drawn from
        the prior probability on the left through the likelihood ratios in
        the center and extended to the posterior probabilities on the right.
<p>
        The likelihood ratio matrix defines quadrants of informativeness
        based on established evidence-based thresholds:
<p>
        <b>Left Upper Quadrant</b>, Likelihood Ratio Positive &gt; 10, Likelihood Ratio
        Negative &lt;0.1:  <b>Exclusion &amp; Confirmation</b>
<p>
        <b>Right Upper Quadrant</b>, Likelihood Ratio Positive &gt;10, Likelihood Ratio
        Negative &gt;0.1:  <b>Confirmation Only</b>
<p>
        <b>Left Lower Quadrant</b>, Likelihood Ratio Positive &lt;10, Likelihood Ratio
        Negative &lt;0.1:  <b>Exclusion Only</b>
<p>
        <b>Right Lower Quadrant</b>, Likelihood Ratio Positive &lt;10, Likelihood Ratio
        Negative &gt;0.1:  <b>No Exclusion or Confirmation</b>
<p>
        
<b><u>Examples</u></b>
<p>
        . use http://repec.org/nasug2007/midas9_example_data.dta
<p>
<p>
    Summary Statistics
<p>
        <b>. midas9 tp fp fn tn, es(g) res(all)</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Table of index-specific results
<p>
        <b>. midas9 tp fp fn tn, es(g) table(dlr)</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
<p>
    Summary ROC Curve with prediction and confidence Contours
<p>
        <b>. midas9 tp fp fn tn, es(g) plot sroc2</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Linear regression test of funnel plot asymmetry
<p>
        <b>. midas9 tp fp fn tn, pubbias</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Funnel plot assessment of publication and other small study biases
<p>
        <b>. midas9 tp fp fn tn, fun</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Forest plot to demonstrate variability
<p>
        <b>. midas9 tp fp fn tn,</b>
            <b>id(author) year(year) ms(0.75)</b>
        <b>for(dss) es(g) texts(0.80)</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Forest plot to demonstrate study-specific on right y-axis
<p>
        <b>.midas9 tp fp fn tn, id(author) year(year)</b>
        <b>es(g) ms(0.75) ford for(dss) texts(0.80)</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Fagan's plot
<p>
        <b>.midas9 tp fp fn tn, es(g) fagan prior(0.20)</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Likelihood Matrix
<p>
        <b>.midas9 tp fp fn tn, es(g) lrmat</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Bivariate Boxplot
<p>
        <b>.midas9 tp fp fn tn, bivbox scheme(s2color)</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
<p>
    Quality Assessment
<p>
        <b>.midas9 tp fp fn tn prodesign ssize30 fulverif testdescr</b>
        <b>refdescr subjdescr report brdspect blinded, qualib</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
    Meta-regression
<p>
        <b>.midas9 tp fp fn tn prodesign ssize30 fulverif testdescr</b>
        <b>refdescr subjdescr report brdspect blinded, es(g) covars</b>
            <i>(</i><i>click to run</i><i>)</i>
<p>
<b><u>Saved results</u></b>
<p>
    <b>midas9</b> saves the following in <b>r()</b>:
<p>
<p>
    Scalars   
<p>
      <b>r(fsens)</b>                fixed effects estimate of summary sensitivity
      <b>r(fspec)</b>                fixed effects estimate of summary specificity
      <b>r(flrn)</b>                 fixed effects estimate of summary likelihood
                                ratio of a negative test
      <b>r(flrp)</b>                 fixed effects estimate of summary likelihood
                                ratio of a positive test
      <b>r(fdor)</b>                 fixed effects estimate of summary diagnostic
                                odds ratio
      <b>r(fldor)</b>                fixed effects estimate of summary diagnostic
                                score
<p>
<p>
<p>
<p>
<p>
      <b>r(mtpr)</b>                 mixed effects estimate of summary sensitivity
      <b>r(mtprse)</b>               standard error of mixed effects estimate of
                                summary sensitivity
      <b>r(mtprlo)</b>               lower bound of mixed effects estimate of
                                summary sensitivity
      <b>r(mtprhi)</b>               upper bound of mixed effects estimate of
                                summary sensitivity
<p>
<p>
      <b>r(mtnr)</b>                 mixed effects estimate of summary specificity
      <b>r(mtnrse)</b>               standard error of mixed effects estimate of
                                summary specificity
      <b>r(mtnrlo)</b>               lower bound of mixed effects estimate of
                                summary specificity
      <b>r(mtnrhi)</b>               upper bound of mixed effects estimate of
                                summary specificity
<p>
<p>
<p>
      <b>r(mlrp) </b>                mixed effects estimate of summary likelihood
                                ratio of a positive test result
      <b>r(mlrpse)</b>               standard error of mixed effects estimate of
                                summary likelihood ratio of a positive test
                                result
      <b>r(mlrplo)</b>               lower bound of mixed effects estimate of
                                summary likelihood ratio of a positive test
                                result
      <b>r(mlrphi)</b>               upper bound of mixed effects estimate of
                                summary likelihood ratio of a positive test
                                result
<p>
<p>
      <b>r(mlrn)</b>                 mixed effects estimate of summary likelihood
                                ratio of a negative test result
      <b>r(mlrnse)</b>               standard error of summary likelihood ratio of a
                                negative test result
      <b>r(mlrnlo)</b>               lower bound of summary likelihood ratio of a
                                negative test result
      <b>r(mlrnhi)</b>               mixed effects estimate of summary likelihood
                                ratio of a negative test result
<p>
<p>
      <b>r(mdor)</b>                 mixed effects estimate of summary diagnostic
                                odds ratio
      <b>r(mdorse)</b>               standard error of summary diagnostic odds ratio
      <b>r(mdorlo)</b>               lower bound of summary diagnostic odds ratio
      <b>r(mdorhi)</b>               upper bound of summary diagnostic odds ratio
<p>
<p>
<p>
      <b>r(mldor)</b>                mixed effects estimate of summary diagnostic
                                score
      <b>r(mldorse)</b>              standard error of summary diagnostic score
      <b>r(mldorlo)</b>              lower bound of summary diagnostic score
      <b>r(mldorhi)</b>              upper bound of summary diagnostic score
<p>
<p>
<p>
      <b>r(AUC)</b>                  Area under summary ROC curve
      <b>r(AUClo)</b>                lower bound of area under summary ROC curve
      <b>r(AUChi)</b>                upper bound of area under summary ROC curve
<p>
<p>
      <b>r(covar)</b>                covariance of logits of sensitivity and
                                specificity
<p>
<p>
      <b>r(rho)</b>                  correlation between logits of sensitivity and
                                specificity
      <b>r(rholo)</b>                lower bound of correlation
      <b>r(rhohi)</b>                upper bound of correlation
      <b>r(reffs1) </b>              variance of logit of sensitivity
      <b>r(reffs1se)</b>             standard error of variance of logit of
                                sensitivity
      <b>r(reffs1lo)</b>             lower bound variance of logit of sensitivity
      <b>r(reffs1hi)</b>             upper bound variance of logit of sensitivity
      <b>r(reffs2) </b>              variance of logit of specificity
      <b>r(reffs2se)</b>             standard error of variance of logit of
                                specificity
      <b>r(reffs2lo)</b>             lower bound variance of logit of specificity
      <b>r(reffs2hi)</b>             upper bound variance of logit of specificity
<p>
<p>
      <b>r(Islrt)</b>                global inconsistency index from likelihood
                                ratio rest
      <b>r(Islrtlo)</b>              lower bound global inconsistency index
      <b>r(Islrthi)</b>              upper bound global inconsistency index
<p>
<p>
<b><u>References</u></b>
<p>
        Begg C.B. and Berlin J.A.  Publication bias: a problem in
        interpreting medical data.  J R Stat Soc A 151 (1988), pp. 419-463.
<p>
        Chu H, Cole SR (2006).  Bivariate meta-analysis of sensitivity and
        specificity with sparse data:  a generalized linear mixed model
        approach.  Journal of Clinical Epidemiology 59:1331-1332.
<p>
        Copas J, Jackson D.(2004) A bound for publication bias based on the
        fraction of unpublished studies.  Biometrics 60:146-153
<p>
        Deeks JJ. Macaskill P and Irwig Les.  The performance of tests of
        publication bias and other sample size effects in systematic reviews
        of diagnostic test accuracy was assessed.  Journal of Clinical
        Epidemiology, Volume 58, Issue 9, September 2005, Pages 882-893.
<p>
        Dinnes J, Deeks J, Kirby J, Roderick P.  A methodological review of
        how heterogeneity has been examined in systematic reviews of
        diagnostic test accuracy.  Health Technol Assess 2005;9(12)
<p>
        Fisher NI, Switzer P (1985) Chi-plots for assessing dependence.
        Biometrika 72, 253-265.
<p>
        Fisher NI, Switzer P (2001) Graphical assessment of dependence: Is a
        picture worth 100 tests?  American Statistician 55, 233-239.
<p>
        Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM (2003) The
        diagnostic odds ratio: a single indicator of test performance.
        Journal of Clinical Epidemiology, Volume 56, Issue 11, November,
        Pages 1129-1135.
<p>
        Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA (2006).  A
        unification of models for meta-analysis of diagnostic accuracy
        studies.  <i>Biostatistics</i> (online advance access).
<p>
        Higgins JP, Thompson SG, Deeks JJ, Altman DG.  Measuring
        inconsistency in meta-analyses [review].  BMJ 2003;327:557-60).
<p>
        Jaeschke R, Guyatt GH, Sackett DL.  Users' guides to the medical
        literature.  III. How to use an article about a diagnostic test.  B.
        What are the results and will they help me in caring for my patients?
        The Evidence-Based Medicine Working Group.  JAMA 1994;271:703-7.
<p>
        Lau J, Schmid CH and Chalmers TC.  Cumulative meta-analysis of
        clinical trials builds evidence for exemplary medical care.  Journal
        of Clinical Epidemiology, Volume 48, Issue 1, January 1995, Pages
        45-57 )
<p>
        Light R.J.and Pillemer D.B..  Summing up: the science of reviewing
        research.  Harvard University Press, Cambridge, MA (1984)
<p>
        Rabe-Hesketh S, Skrondal A (2005).  <i>Multilevel and Longitudinal</i>
        <i>Modeling Using Stata.</i>  College Station, TX: Stata Press.
<p>
        Rabe-Hesketh S, Skrondal A, Pickles A (2004).  GLLAMM Manual.  <i>U.C.</i>
        <i>Berkeley Division of Biostatistics Working Paper Series.</i>  Working
        Paper 160.
<p>
        Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM,
        Zwinderman AH .  Bivariate analysis of sensitivity and specificity
        produces informative summary measures in diagnostic reviews.  <i>Journal</i>
        <i>of Clinical Epidemiology</i> (2005) 58:982-990.
<p>
        Riley RD, Abrams KR, Sutton AJ, Lambert P, Thompson JR (2005).  The
        benefits and limitations of multivariate meta-analysis, with
        application to diagnostic and prognostic studies.  University of
        Leicester Medical Statistics Group Technical Report Series.
        Technical Report 05-04.
<p>
        Rutter CM, Gatsonis CA (2001).  A hierarchical regression approach to
        meta-analysis of diagnostic test accuracy evaluations.  <i>Statistics in</i>
        <i>Medicine</i> 20:2865-2884.
<p>
        Skupski DW, Rosenberg CR, Eglinton GS (2002) Intrapartum Fetal
        Stimulation Tests: A Meta-Analysis.  Obstet. Gynecol. 99: 129 - 134.
<p>
        Song F, Khan K, Dinnes J. and Sutton A.J.  Asymmetric funnel plots
        and publication bias in meta-analyses of diagnostic accuracy.  Int J
        Epidemiol 31 (2002), pp. 88-95
<p>
<p>
        StataCorp. 2007.  Stata Statistical Software: Release 10 College
        station, TX:  StataCorp LP.
<p>
<p>
        Swets JA.  Measuring the accuracy of diagnostic systems.  Science.
        1988;240:1285-1293.
<p>
        van Houwelingen H.C. , Arends L.R. and Stijnen T.  Advanced methods
        in meta-analysis: multivariate approach and meta-regression, Stat Med
        21 (2002) (4), pp. 589-624.
<p>
        van Houwelingen H.C., Zwinderman K.H. and Stijnen T.  A bivariate
        approach to meta-analysis, Stat Med 12 (1993) (24), pp. 2273-2284
<p>
        Wang, MC Bushman BJ using the normal quantile plot to explore
        meta-analytic data sets.  Psychological methods (1998) 3;46-54
<p>
<p>
<b><u>Author</u></b>
<p>
        Ben A. Dwamena, Division of Nuclear Medicine, Department of
        Radiology, University of Michigan, USA Email bdwamena@umich.edu for
        problems, comments and suggestions
<p>
<b><u>Citation</u></b>
<p>
        Users should please reference program in any published work as:
        Dwamena, Ben A.(2007)<b> midas9: Computational and Graphical Routines</b>
        <b>for Meta-analytical Integration of Diagnostic Accuracy Studies in</b>
        <b>Stata.</b>  Division of Nuclear Medicine, Department of Radiology,
        University of Michigan Medical School, Ann Arbor, Michigan.
<p>
<b><u>Acknowledgement</u></b>
<p>
Thanks to
<p>
        -Roberto Gutierrez and the Stata Development team for xtmelogit and
        all that Stata offers....
<p>
        -Richard Sylvester and Ruth Carlos for encouragement, suggestions and
        testing of midas9
<p>
        -Richard Riley for trusting me with pre-prints of his work on
        bivariate meta-analysis.
<p>
        -Joseph Coveney for posting syntax for the bivariate model using 
        gllamm on Statalist.
<p>
        -Sophia-Rabe-Hesketh and other authors of gllamm for their work.
<p>
        -Derek Wenger for assistance with coding Fagan's plot.
<p>
        -Nick Cox for his polarsm which was adapted for <b>bivbox</b> option in 
        midas9 and for mylabels.
<p>
        -Roger Harbord for his metareg, metafunnel and metamodbias programs
        which provided very useful ideas for midas9.
<p>
        -Mike Bradburn ( and R Harris) for metan which was used to implement
        cumulative and influence meta-analyses in midas9.
<p>
<b><u>Also see</u></b>
<p>
        On-line: help for metan (if installed), gllamm (if installed), 
        mylabels (if installed)
<p>
        
</pre>